Delayed diagnosis of cardiac myxoma with antiphospholipid syndrome caused recurrent embolic strokes presenting as cognitive decline, resolved after tumor removal.
This case highlights the necessity of comprehensive structural cardiac evaluation (e.g., TEE) in young patients with embolic strokes, even when a prothrombotic condition like APS is already identified.
Absolute Event Rate: 0% vs 0%
A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to small vessel ischaemia, delaying appropriate evaluation. Over 2 years, serial MRIs revealed multiple new cortical infarcts. Stroke workup confirmed antiphospholipid syndrome (APS) yet continued concern for a persistent embolic source prompted trans-oesophageal echocardiography, which revealed a mass on the posterior mitral leaflet. Surgical excision confirmed a benign cardiac myxoma with no further embolic events on follow-up. This case illustrates how neuro-embolic events can manifest as non-specific psychiatric or cognitive symptoms, and how early assumptions may delay appropriate diagnosis. Even after diagnosing a prothrombotic condition like APS, clinicians must look for structural cardiac lesions that may coexist and amplify embolic risk. Comprehensive aetiological assessment is essential in embolic stroke of undetermined source, especially in younger patients with atypical presentations.
George et al. (Sun,) reported a other. Delayed diagnosis of cardiac myxoma with antiphospholipid syndrome caused recurrent embolic strokes presenting as cognitive decline, resolved after tumor removal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: